Alumis, Inc. (ALMS)
6.85
-0.36
(-4.99%)
USD |
NASDAQ |
Oct 02, 16:00
6.845
0.00 (0.00%)
After-Hours: 20:00
Alumis Enterprise Value : 414.40M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 414.40M |
| October 01, 2026 | 460.66M |
| September 30, 2026 | 483.79M |
| September 29, 2026 | 470.94M |
| September 28, 2026 | 454.23M |
| September 25, 2026 | 446.52M |
| September 24, 2026 | 470.94M |
| September 23, 2026 | 490.21M |
| September 22, 2026 | 576.31M |
| September 21, 2026 | 549.33M |
| September 18, 2026 | 532.62M |
| September 17, 2026 | 539.05M |
| September 16, 2026 | 554.47M |
| September 15, 2026 | 613.58M |
| September 14, 2026 | 718.95M |
| September 11, 2026 | 713.81M |
| September 10, 2026 | 806.34M |
| September 09, 2026 | 793.49M |
| September 08, 2026 | 893.72M |
| September 04, 2026 | 960.54M |
| September 03, 2026 | 993.96M |
| September 02, 2026 | 864.16M |
| September 01, 2026 | 751.08M |
| August 31, 2026 | 2.337B |
| August 28, 2026 | 2.410B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.517B |
| August 26, 2026 | 2.569B |
| August 25, 2026 | 2.613B |
| August 24, 2026 | 2.494B |
| August 21, 2026 | 2.640B |
| August 20, 2026 | 2.472B |
| August 19, 2026 | 2.617B |
| August 18, 2026 | 2.731B |
| August 17, 2026 | 2.811B |
| August 14, 2026 | 2.787B |
| August 13, 2026 | 2.671B |
| August 12, 2026 | 2.817B |
| August 11, 2026 | 2.794B |
| August 10, 2026 | 3.072B |
| August 07, 2026 | 3.081B |
| August 06, 2026 | 3.107B |
| August 05, 2026 | 3.019B |
| August 04, 2026 | 3.019B |
| August 03, 2026 | 2.891B |
| July 31, 2026 | 3.164B |
| July 30, 2026 | 3.254B |
| July 29, 2026 | 2.924B |
| July 28, 2026 | 3.008B |
| July 27, 2026 | 3.014B |
| July 24, 2026 | 3.132B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 644.86B |
| Corcept Therapeutics, Inc. | 12.24B |
| Aclaris Therapeutics, Inc. | 524.12M |
| BioAge Labs, Inc. | -13.32M |
| ANI Pharmaceuticals, Inc. | 1.893B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -142.22M |
| Revenue (Quarterly) | 1.662M |
| Total Expenses (Quarterly) | 143.88M |
| EPS Diluted (Quarterly) | -1.114 |
| Gross Profit Margin (Quarterly) | 47.41% |
| Profit Margin (Quarterly) | -8.56K% |
| Earnings Yield | -55.61% |
| Normalized Earnings Yield | -51.11 |